Pfizer tests anti–COVID-19 drug in Brazilians

The clinical tests of a drug against COVID-19 started being conducted in Brazil. Developed by Pfizer, the research uses molecule PF-07321332, an antiviral of the class of protease inhibitors. According to the pharmaceutical company, the medicine, administered orally, has shown potential to be used against the novel coronavirus. A total of 29 research centers are […]

Fonte